Clinical Trial Update: A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of interleukin-2 (IL-2) alone in HIV-positive patients uncontrolled by anti-HIV therapy with CD4 counts ≥350 cells/mm3; com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED